Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.
暂无分享,去创建一个
R. Labianca | M. Buyse | L. Påhlman | C. Punt | P. Hohenberger | C. Köhne | J. Douillard | H. Schmoll | A. Sobrero
[1] D. Sargent,et al. Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer. , 2006, Clinical colorectal cancer.
[2] Y. Ohashi,et al. Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil , 2006, Langenbeck's Archives of Surgery.
[3] N. Petrelli,et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] P. Catalano,et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Douillard,et al. Adjuvant chemotherapy for colon cancer: a confusing area! , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] D. Sargent,et al. Definition of disease-free survival: this is my truth-show me yours. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] F. di Costanzo,et al. Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer , 2005, British Journal of Cancer.
[8] T. Conroy,et al. Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. , 2005, The Lancet. Oncology.
[9] Y. Ohashi,et al. A multicenter randomized study comparing 5-fluorouracil continuous infusion (ci) plus 1-hexylcarbamoyl-5-fluorouracil and 5-FU ci alone in colorectal cancer. , 2005, Oncology reports.
[10] Markus Abt,et al. Capecitabine as adjuvant treatment for stage III colon cancer. , 2005, The New England journal of medicine.
[11] R. Labianca,et al. Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3) , 2005 .
[12] N. Wolmark,et al. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07 , 2005 .
[13] A. Kopp-Schneider,et al. Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study* , 2005, Oncology Research and Treatment.
[14] M. Gnant,et al. A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer , 2005, British Journal of Cancer.
[15] G. Weiss,et al. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] P. Bruzzi,et al. Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer , 2004, British Journal of Cancer.
[17] Daniel J Sargent,et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] R. Porschen,et al. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion , 2005, International Journal of Colorectal Disease.
[19] M. Kohli,et al. Re: Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. , 2004, Journal of the National Cancer Institute.
[20] Charles R. Thomas,et al. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[22] R. Labianca,et al. Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma. , 2004, Journal of the National Cancer Institute.
[23] D. Lowy,et al. Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles , 2004 .
[24] T. Nakajima,et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study , 2004, British Journal of Cancer.
[25] Y. Ohashi,et al. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer , 2004, International Journal of Colorectal Disease.
[26] S. Yasuda,et al. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma , 2004, Cancer.
[27] N. Wolmark,et al. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. , 2004, Journal of the National Cancer Institute.
[28] Y. Ohashi,et al. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur , 2004, International Journal of Clinical Oncology.
[29] K. Sugimachi,et al. Pre- and post-operative adjuvant chemotherapy in colorectal cancer. , 2003, International journal of oncology.
[30] R. James,et al. Randomized clinical trial of adjuvant radiotherapy and 5‐fluorouracil infusion in colorectal cancer (AXIS) , 2003, The British journal of surgery.
[31] C. Boni,et al. Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] S. Shin,et al. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. , 2003, Yonsei medical journal.
[33] Marc Buyse,et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] M. Miyazaki,et al. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines. , 2003, International journal of oncology.
[35] R. Porschen,et al. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] A. Piga,et al. The Role of Levamisole in the Adjuvant Treatment of Stage III Colon Cancer Patients: A Randomized Trial of 5-Fluorouracil and Levamisole Versus 5-Fluorouracil Alone , 2003, Cancer investigation.
[37] Results of a randomized trial with or without 5-FU-based preoperative chemotherapy followed by postoperative chemotherapy in resected colon and rectal carcinoma. , 2003, Japanese journal of clinical oncology.
[38] A. Kopp-Schneider,et al. Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin , 2002, Oncology Research and Treatment.
[39] C. Punt,et al. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study , 2002, The Lancet.
[40] Y. Ohashi,et al. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial , 2002, Langenbeck’s Archives of Surgery.
[41] G. Androulakis,et al. Adjuvant systemic therapy protocol for Dukes' B2 and C resectable colon carcinoma. , 2002, Tumori.
[42] T. Wiggers,et al. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III , 2001, British Journal of Cancer.
[43] R. Porschen,et al. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] K. Orita,et al. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer. , 2000, Anticancer research.
[45] C. Focan,et al. Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trial , 2000, Anti-cancer drugs.
[46] D. Kerr,et al. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial , 2000, The Lancet.
[47] J. Plukker,et al. The addition of low-dose leucovorin to the combination of 5-fluorouracillevamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer , 2000 .
[48] B. Nordlinger,et al. Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. , 2000, Annals of surgery.
[49] U. Dafni,et al. Fluorouracil and Leucovorin with or without Interferon Alfa-2a as Adjuvant Treatment, in Patients with High-Risk Colon Cancer , 2000, Oncology.
[50] K. Eida,et al. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer. , 2000, Anticancer research.
[51] H. Fukuda,et al. European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .
[52] J. Manola,et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] J. Hermans,et al. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[54] H. Rockette,et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] M. Hanna,et al. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial , 1999, The Lancet.
[56] J. Bryant,et al. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05. , 1998, Journal of the National Cancer Institute.
[57] R. Labianca,et al. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial , 1998, The Lancet.
[58] Alberto Zaniboni,et al. GIVIO‐SITAC 01 , 1998, Cancer.
[59] J. Witte,et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] W. Scheithauer,et al. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. , 1998, British Journal of Cancer.
[61] H. Rauschecker,et al. Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. , 1997, European journal of cancer.
[62] H. Wieand,et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] C. Tangen,et al. Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report , 1995, Annals of Internal Medicine.